ACHE and Alzheimer disease: Presently, the FDA has approved three inhibitors of acetylcholinesterase enzymes (AChE)—donepezil, galantamine, and rivastigmine—as well as one antagonist of the (NMDA) receptor, known as memantine for AD treatment [24,25].